Innovation

A section of The Report on life sciences focusing on the biotechnology sector. Oh, just a reminder: the material posted about life science is a draft. More editing will occur before it’s in final form. I welcome your input.

Geez, I’m kind of overwhelmed by all the data for The Report. The life science sector is so big and complex. There’s no end to the information. I’ve had to say, “Enough!” to myself just to get started. Also the importance of the market-driven sector in cancer management keeps growing in my mind. I think this is key to anyone ...

Innovation is a theme of FI Center and of FISpace. It’s also a topic getting attention today nationally because, whatever their position on the “offshoring” issue, virtually everyone agrees that future prosperity in the US depends on being innovative, not on commodity ideas and labor. Also, the pharmaceutical industry about which I’m writing is having a crisis over innovation—or, rather, ...

Having gushed effusively about Leroy Hood, I’d like to turn to the China part of the conference. First, through, one last note about Hood. He had three messages for the Chinese: Everything he’s ever done that was important (including current work) has been met with great resistance. It’s not too late to get in on the ground floor of systems ...